logo
Chenab bridge: How project team navigated through steep slopes on horses and mules

Chenab bridge: How project team navigated through steep slopes on horses and mules

KATRA: To realise the vision of travelling from "Kashmir to Kanyakumari" by rail, the project team behind the construction of the Chenab bridge faced several challenges. Among them was how to reach the location surrounded by the steep slopes of the Himalayas.
The team had only one option -- horses and mules.
According to Afcons Infrastructure Limited, the top infrastructure company that constructed the bridge, one of the main and earliest challenges was access to the bridge location, to transport equipment and construction materials.
"Initially, mules and horses were used by the project team to reach the location. Slowly over a period, temporary roads were created and access was made available to the site," a spokesperson from the company said.
Prime Minister Narendra Modi on Friday inaugurated the iconic Chenab Bridge, Anji Rail Bridge and Udhampur-Srinagar-Baramulla Rail Link project and flagged off Vande Bharat trains, connecting Katra to Srinagar.
The spokesperson added that eventually, on the North side of the river bank, an 11-km road was constructed and a 12-km road on the South side.
Krishnamurthy Subramanian, Executive Vice Chairman, Afcons, said the Chenab Railway Bridge is more than just a marvel of engineering. "It is a symbol of India's resolve to conquer the most formidable challenges with ingenuity and courage," he told PTI.
The company used the world's tallest crossbar cable cranes and specialised heavy machinery as tools for this ambitious project.
"The ancient and steep slopes of the Himalayas were tamed using massive consolidation grouting, making them sturdy for the colossal arch foundations," the company said, highlighting challenges it faced.
"With the foundations set, the erection of the arch from both sides was planned by the cantilever construction technique. The first big moment of triumph came on April 5, 2021, when a single majestic arch approaching steadily from both banks met at the crown," it added.
"The viaduct construction was another unique challenge. There were multiple transition areas. Keeping this in mind, the launching sequence was meticulously planned in four sections," the spokesperson said.
Giridhar Rajagopalan, Deputy Managing Director, Afcons, told PTI that for the first time in Indian Railways, incremental launching was done on a transition curve and a longitudinal gradient, both occurring at the same location, for the deck launching of the viaduct portion of the Chenab Bridge.
S Paramasivan, Managing Director, Afcons, "For Afcons, it represents our unwavering commitment to nation-building and our ability to reimagine infrastructure in the toughest terrains. This bridge will inspire generations of engineers and stands as a tribute to the power of Indian engineering and teamwork."
For the first time in the Indian Railways' history, a laboratory accredited by the National Accreditation Board for Testing and Calibration (NABL) was set up to ensure that quality was being monitored at every stage of the project.
Situated at a height of 359 metres above the river, the Chenab bridge is 35 metres higher than the iconic Eiffel Tower in Paris and the world's highest railway bridge over the Chenab river.
After inaugurating the Chenab bridge, PM Modi walked on it holding the Tricolour high. He travelled in a rail engine coach to reach the spot.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Railway Minister: 'Make in India' boosting rail exports, coaches sent to Australia, bogies to UK
Railway Minister: 'Make in India' boosting rail exports, coaches sent to Australia, bogies to UK

Time of India

time8 minutes ago

  • Time of India

Railway Minister: 'Make in India' boosting rail exports, coaches sent to Australia, bogies to UK

Railway Minister Ashwini Vaishnaw visited Alstom's coach manufacturing unit in Vadodara, where metro and intercity train coaches are being built for Indian and international routes. He highlighted India's growing rail exports under the 'Make in India, Make for the World' vision, with coaches and components being shipped to countries including Australia, Canada, UK, Saudi Arabia, and France. Show more Show less

IT sector not broken, but evolving, says TRUST MF's CIO Mihir Vohra; shares top sectoral bets
IT sector not broken, but evolving, says TRUST MF's CIO Mihir Vohra; shares top sectoral bets

Mint

time8 minutes ago

  • Mint

IT sector not broken, but evolving, says TRUST MF's CIO Mihir Vohra; shares top sectoral bets

Mihir Vora, CIO, TRUST Mutual Fund, believes that the Indian stock market could step out of its consolidation zone once global volatility subsides and investor focus returns to earnings. Meanwhile, Vohra remains unperturbed by the ongoing FII selloff, as DII support and SIP inflows bolster confidence in equity demand. He is bullish on select sectors like infrastructure, logistics, and defence suppliers, NBFCs, among others. Edited excerpts: The Nifty has been churning in a tight band for several weeks. The domestic and global macroeconomic and geopolitical setup has many moving parts, and markets are probably waiting for a reduction in uncertainty. Globally, US trade negotiations are still on, and the US Dollar continues to be weak in spite of high bond yields. Domestically, the long-term macro parameters are healthy – low inflation, improving current account deficit and fiscal deficit. Consumption indicators are a mixed bag, and credit growth has not yet picked up in spite of ample liquidity and rate cuts. In the short term, the earnings season has seen a mix of negative and positive surprises. Sustained earnings growth remains key for the market. If global volatility subsides and investor focus returns to domestic earnings, that could be enough to lift sentiment. Clarity on a U.S.–India trade agreement by the August 1 deadline can also be a catalyst. Foreign portfolio investors have turned cautious again — derivative positioning suggests the most bearish sentiment in months. That may continue until we get clear signals on U.S. Fed policy or trade developments. In the medium to long-term, if the US Dollar continues to remain relatively weak, we should see sustained flows to countries like India. We see FPI selling as cyclical rather than structural. In time, India's superior long-term macro, demographics and higher growth should bring global interest back. India also has a strong internal support system: domestic institutions remain net buyers, and record retail SIP flows continue to underpin demand. Overall, we have an underweight stance in the IT sector. We are tackling the sector exposure selectively, preferring midcap IT names and digital infra providers with stronger growth visibility, rather than overcrowded large caps. Even within the blue-chips, firms executing well on AI/automation and client-based cost takeout remain interesting. The sector isn't broken — it's just evolving. While the leading IT giants delivered subdued numbers — flat revenues, soft global deal wins — valuations are now trading closer to historical norms than early 2024 extremes. Our growth conviction remains highest in capex, power transmission, infrastructure logistics, and defence suppliers—segments with visible order books, operating leverage, and a longer runway of growth. However, we are selective as these segments have become quite popular and valuations are not uniformly attractive. Financials offer opportunities in NBFCs and banks, with expectations of improving credit growth and asset quality. Auto ancillaries and engineering services/export plays are also showing promise as the global capex cycle recovers. In healthcare, the stories are more stock-specific, and we like the CDMO space and hospitals. After sharp rallies in many names, investors have started booking profits. The pullback is a natural consolidation, not a capitulation. The long-term fundamentals — rising defence budgets, dual-use platform opportunities, and improving export arcs — remain intact. Stock selection is critical now. We favour robust balance sheets, clear execution histories, and firms with pipeline visibility. Yes, we launched our third equity fund, the Multicap Fund. This continues our efforts to offer funds in all the core categories to our investors and distributors, the first two being the Flexi Cap and Small Cap funds. The Multicap category is a core category and is suitable for most investors who want a diversified exposure to the stock market. Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Nifty Pharma Index rises 1% amid weak India Stock Markets: Cipla and Laurus Labs among key gainers
Nifty Pharma Index rises 1% amid weak India Stock Markets: Cipla and Laurus Labs among key gainers

Mint

time8 minutes ago

  • Mint

Nifty Pharma Index rises 1% amid weak India Stock Markets: Cipla and Laurus Labs among key gainers

Stock Market Today: The Nifty Pharma Index gained more than 1% amid a weak Indian stock market on a day when the benchmark Nifty 50 Index dipped 0.3-0.4% during the intraday trades. Cipla and Laurus Labs stood among the key gainers The Nifty Pharma index, showing its resilience, gained more than 1% during the intraday trades. The Nifty Pharma Index, which opened at 22690.50 on Monday, went to scale highs of 22,908.40, marking gains of more than 1% over the previous day's close of 22662.70. Laurus Labs, with gains of more than 7%, followed by Cipla, with gains of close to 2%, stood among key gainers. Glenmark Pharmaceuticals and Gland Pharma also gained more than 1%, helping drive gains. Nifty Pharma and Healthcare index have been showing resilience amid volatile stock markets since last few weeks While Nifty Pharma & Healthcare are the lone warriors displaying outperformance amidst this downfall in the markets, we expect sectors such as IT, Defense, Oil & Gas, Realty & CPSE to appear bearish and may continue to underperform in the near term, given their weak price structures and lackluster momentum indicators., said Sudeep Shah, Vice President and Head of Technical and Derivative Research, SBI Securities Technically, Cipla, Apollo Hospital are likely to outperform in the short term, as per Shah. The Indian Pharma index performance is also being helped by strong Indian Pharma market growth. The IPM growth during the month of June 2025 stood at a strong 11.5%, as per reports. Glemmark Pharmaceuticals, JB Chemicals and Pharmaceuticals, Mankind Pharma FDC Ltd, Alkem, Zydus, and Torrent were among the key outperformers as per Nuvama. While the pharma market is growing, the challenge is provided by rising generic sales and Jan Aushadhi Kendras. However, amidst challenges, Within formulations, Sun, Cipla, Lupin and Emcure are the top picks. of Kotak Institutional Equities Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store